{"name":"Bing Han","slug":"bing-han","ticker":"","exchange":"","domain":"","description":"Han Bing is a Chinese ice dancer. She competed in the ice dance event at the 1992 Winter Olympics.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"enatumab","genericName":"enatumab","slug":"enatumab","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"enatumab","genericName":"enatumab","slug":"enatumab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5abHV3aUJjWVpoeGtsZzVlRzNONE52S0ljXzJNZ1BHbkdEV255cjN6WUd6UlNQNTNnc3NXZHVCbXBRamJxcC12ZHNhcG5LOWRsSjE5NU9EeFRYek44VFdaT29HVTRfamM?oc=5","date":"2025-04-02","type":"pipeline","source":"ACS Publications","summary":"Iron-Catalyzed Site-Selective Bromination of Benzylic C(sp3)–H Bonds - ACS Publications","headline":"Iron-Catalyzed Site-Selective Bromination of Benzylic C(sp3)–H Bonds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1aRXFDVWlaR3ZxTi0zbWVKY3FiT2JMbTExRi11VkFNTUNEMzFTaGc4VWxaSVpMNUxUOXBBVmhBOXp4NWxvR2V4a3RCRnE3QlpnWm90ajc3c2laWVNIelZ4eEZR?oc=5","date":"2025-04-02","type":"pipeline","source":"ACS Publications","summary":"Iron-Catalyzed Site-Selective Bromination of Benzylic C(sp3)–H Bonds - ACS Publications","headline":"Iron-Catalyzed Site-Selective Bromination of Benzylic C(sp3)–H Bonds","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-12-10","type":"regulatory","source":"PR Newswire","summary":"Kira Pharmaceuticals Presents Updated Data of Phase 2 Study of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH) at American Society of Hematology (ASH) 2024 Demonstrating Long-Term Safety and Effica","headline":"Kira Pharmaceuticals Presents Updated Data of Phase 2 Study of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH) at Ame","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9WWC0zOVpBVS1mMjJtenpQdFVuSk4xTWM4cXBtYjRQVzhSOHhsc1JtaVhrWXdxMzRlQzJ3NmZLdmdhd2NuaHdpQ0hPekNvSS0yWW1iRVVPeFNBX3FNbDJUajJn?oc=5","date":"2024-05-29","type":"pipeline","source":"ACS Publications","summary":"Copper-Catalyzed Asymmetric Kinugasa/Michael Addition Cascade Reactions for the Synthesis of Chiral Spiro β-Lactams - ACS Publications","headline":"Copper-Catalyzed Asymmetric Kinugasa/Michael Addition Cascade Reactions for the Synthesis of Chiral Spiro β-Lactams","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9vU3U3SFJvdW51dEQ2ZEZIVmJaUTdiSHJMMC1MYW5jV0dxcjEyX18wMnhRZUp3QVppZndvdHZuTElpd2pITG5wVjNrM3NtbFUzWGR1alNieU9FcHFIRWNJ?oc=5","date":"2023-11-02","type":"pipeline","source":"nature.com","summary":"Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia - nature.com","headline":"Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}